Literature DB >> 24346851

Gender differences in pharmacokinetics of a combination tablet of niacin extended-release/simvastatin in healthy Chinese volunteers.

Xiao-lin Wang1, Man Liu, Man Yang, Ya-nan Zhang, Dan Zhang, Li-na Zhang, Jing Han, Hui-chen Liu.   

Abstract

The gender differences in pharmacokinetics of a combination tablet of niacin extended-release/simvastatin were evaluated in healthy Chinese volunteers. Thirty-six healthy male and female volunteers were enrolled in the study receiving a single oral dose of niacin extended-release/simvastatin 1,000/20 mg. The results indicated that the systemic exposure of simvastatin hydroxy acid and the total urine excretion of niacin were significantly higher for females compared with those for males, and the T max of niacin in plasma was significantly shorter for males than that for females. There were no significant differences in the systemic exposure of simvastatin, niacin, and NUA in plasma between males and females.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24346851     DOI: 10.1007/s13318-013-0169-2

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  14 in total

1.  Pharmacokinetic comparison of controlled-release and immediate-release oral formulations of simvastatin in healthy Korean subjects: a randomized, open-label, parallel-group, single- and multiple-dose study.

Authors:  Seong Bok Jang; Yoon Jung Lee; Lay Ahyoung Lim; Kyung-Mi Park; Bong-Ju Kwon; Jong Soo Woo; Yong-Il Kim; Min Soo Park; Kyung Hwan Kim; Kyungsoo Park
Journal:  Clin Ther       Date:  2010-01       Impact factor: 3.393

2.  Simultaneous determination of niacin, niacinamide and nicotinuric acid in human plasma.

Authors:  P Pfuhl; U Kärcher; N Häring; A Baumeister; Mona Abdel Tawab; M Schubert-Zsilavecz
Journal:  J Pharm Biomed Anal       Date:  2005-01-04       Impact factor: 3.935

3.  Validated HPLC-MS/MS method for simultaneous determination of simvastatin and simvastatin hydroxy acid in human plasma.

Authors:  B Barrett; J Huclová; V Borek-Dohalský; B Nemec; I Jelínek
Journal:  J Pharm Biomed Anal       Date:  2005-12-27       Impact factor: 3.935

Review 4.  Niacin and its metabolites: role of LC-MS/MS bioanalytical methods and update on clinical pharmacology. An overview.

Authors:  Ramesh Mullangi; Nuggehally R Srinivas
Journal:  Biomed Chromatogr       Date:  2010-11-05       Impact factor: 1.902

5.  Simultaneous determination of niacin and its metabolites--nicotinamide, nicotinuric acid and N-methyl-2-pyridone-5-carboxamide--in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.

Authors:  Jaswanth Kumar Inamadugu; Rajasekhar Damaramadugu; Ramesh Mullangi; Venkateswarlu Ponneri
Journal:  Biomed Chromatogr       Date:  2010-10       Impact factor: 1.902

6.  The comparative bioavailability of an extended-release niacin and lovastatin fixed dose combination tablet versus extended-release niacin tablet, lovastatin tablet and a combination of extended-release niacin tablet and lovastatin tablet.

Authors:  R Menon; D Tolbert; E Cefali
Journal:  Biopharm Drug Dispos       Date:  2007-09       Impact factor: 1.627

7.  An improved and fully validated LC-MS/MS method for the simultaneous quantification of simvastatin and simvastatin acid in human plasma.

Authors:  Constantinos Apostolou; Constantinos Kousoulos; Yannis Dotsikas; Georgios-Stefanos Soumelas; Filomila Kolocouri; Afroditi Ziaka; Yannis L Loukas
Journal:  J Pharm Biomed Anal       Date:  2007-12-08       Impact factor: 3.935

8.  Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation.

Authors:  R M Menon; M H Adams; M A González; D S Tolbert; J H Leu; E A Cefali
Journal:  Int J Clin Pharmacol Ther       Date:  2007-08       Impact factor: 1.366

9.  Simultaneous determination of simvastatin and simvastatin acid in human plasma by LC-MS/MS without polarity switch: application to a bioequivalence study.

Authors:  Bhavin N Patel; Naveen Sharma; Mallika Sanyal; Pranav S Shrivastav
Journal:  J Sep Sci       Date:  2008-02       Impact factor: 3.645

Review 10.  Niacin extended-release/simvastatin.

Authors:  Mark Sanford; Monique P Curran
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more
  1 in total

1.  Biorelevant In Vitro Release Testing and In Vivo Study of Extended-Release Niacin Hydrophilic Matrix Tablets.

Authors:  Bartłomiej Milanowski; Arkadiusz Hejduk; Marek A Bawiec; Emilia Jakubowska; Agnieszka Urbańska; Anna Wiśniewska; Grzegorz Garbacz; Janina Lulek
Journal:  AAPS PharmSciTech       Date:  2020-01-27       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.